Cancer News and Research

Latest Cancer News and Research

Noncommunicable diseases need more attention among prisoners

Prisons are not taking appropriate action to improve diet and increase physical activity levels to help prevent noncommunicable diseases among prisoners, say UK researchers in The Lancet.

31 May 2012

Common pain killers linked to decreased skin cancer risk

Use of nonsteroidal anti-inflammatory drugs is associated with a decreased risk for skin cancer, particularly squamous cell carcinoma and malignant melanoma, study findings indicate.

31 May 2012

Smoker's genetic makeup can help predict response to drug therapy

The same gene variations that make it difficult to stop smoking also increase the likelihood that heavy smokers will respond to nicotine-replacement therapy and drugs that thwart cravings, a new study shows.

31 May 2012

New method can solve 3-D structures of integral membrane proteins

A new method for rapidly solving the three-dimensional structures of a special group of proteins, known as integral membrane proteins, may speed drug discovery by providing scientists with precise targets for new therapies, according to a paper published May 20 in Nature Methods.

31 May 2012

4,600 lives could be saved a year by cutting daily alcohol intake to half a unit (5g)

Cutting daily alcohol intake to just over half a unit (5 g), could save 4,600 lives a year in England, say experts in the online journal BMJ Open.

31 May 2012

Taiho to initiate TAS-102 Phase III trial in colorectal cancer

Taiho Pharmaceutical Co., Ltd. announced on May 31 that a global Phase III clinical trial (RECOURSE) for the novel combination antimetabolite TAS-102 will start in June this year.

31 May 2012

UCLA research projects aim to improve lives of children with serious illnesses

New hope for deadly pediatric brain tumors; opening the door to improved diagnosis and treatment of epilepsy in children; and advanced genetic testing to better understand the causes of autism and cancer in kids. These research projects are currently underway at Mattel Children's Hospital UCLA under the umbrella of the UCLA Children's Discovery and Innovation Institute (CDI), and aim to dramatically improve the lives of children with serious illnesses.

31 May 2012

ProCure Proton Therapy Center successfully treats first cancer patient

Bound Brook, N.J. resident Frank Mackinson became the first patient to complete treatment at the ProCure Proton Therapy Center in Somerset, N.J.— a milestone that was celebrated with family, friends and Mackinson's treatment team. The Somerset Center opened officially on March 20 (one month ahead of schedule), enabling Mackinson to begin treatment on March 28. Proton therapy is a precise form of radiation treatment for cancer without many of the short- and long-term side effects often experienced with standard X-ray radiation.

31 May 2012

TSRI receives $2 million donation from Esther B. O'Keeffe Charitable Foundation

The Esther B. O'Keeffe Charitable Foundation has made a $2 million donation to The Scripps Research Institute to fund biomedical research and education on the Florida campus. In recognition of the gift, the Founders Room and the adjoining board room at Scripps Florida have been named the Esther B. O'Keeffe Founders Suite.

31 May 2012

Simple blood test can detect genetic faults in patients with cancer

A simple and cost-effective blood test could be used to monitor how a patient is responding to treatment and detect genetic faults in their cancer as they happen, according to a Cancer Research UK study.

31 May 2012

YCC, SCRI and SCH partner to advance cancer research

Sarah Cannon Research Institute (SCRI) today announced the finalization of an agreement to collaborate scientifically with Yale Cancer Center (YCC) and Smilow Cancer Hospital at Yale-New Haven (SCH) to advance cancer research.

31 May 2012

Data from Response Genetics' tests against cancer to be presented at ASCO 2012

Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, announced today four presentations to be held during the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL from June 1 to June 5, 2012. Study results are based on the company's proprietary technology and approach.

31 May 2012

Pharmspective releases ‘Molecular Diagnostics Insights in Oncology’

Pharmspective, LLC today announced the release of its second syndicated report – Molecular Diagnostics Insights in Oncology. This new extensive survey of over 400 oncologists characterizes the emerging molecular diagnostics landscape and the role and influence of specific assays in clinical management and therapy selection.

31 May 2012

Foundation Medicine introduces first pan-cancer genomic profile

Foundation Medicine announced today the commercial launch of FoundationOne, the first pan-cancer, fully informative genomic profile designed to help oncologists expand their patients' treatment options.

31 May 2012

Study examines how SMIP-016 drug kills CLL cells

A new study has identified a life-and-death signaling role for a molecule on the surface of the immune cells involved in the most common form of chronic leukemia. The finding could lead to more effective therapy for chronic lymphocytic leukemia (CLL), an as yet incurable cancer that occurs in more than 16,000 Americans annually.

31 May 2012

CTI announces results from PIX301 phase 3 trial of Pixuvri for NHL

Cell Therapeutics, Inc. today announced that results from its PIX301 phase 3 clinical trial of Pixuvri (pixantrone) have been published online in The Lancet Oncology.

31 May 2012

GE to provide attendees with overview of new oncology solutions at ASCO annual meeting

GE Healthcare, is working to help physicians potentially improve patient care throughout the breast cancer journey through one of the most comprehensive portfolios of technologies in the industry available today.

31 May 2012

Genetics can predict success of smoking cessation and need for medications

Genetics can help determine whether a person is likely to quit smoking on his or her own or need medication to improve the chances of success, according to research published in today's American Journal of Psychiatry. Researchers say the study moves health care providers a step closer to one day providing more individualized treatment plans to help patients quit smoking.

31 May 2012

TAU researcher develops new antibodies to target and destroy cancer cells

Because cancer cells grow very quickly, chemotherapy is designed to target cells whose numbers grow rapidly. But this treatment comes with a heavy price - many healthy cells essential for body functions are also targeted and killed by the toxin. This dangerous side-effect has prompted researchers to seek better and more selective ways to kill cancer cells inside the body.

31 May 2012

AAPS honors Morphotek with 2012 Excellence in Ligand Binding Assays Award

Morphotek, Inc., a subsidiary of Eisai Inc., announced today that The American Association of Pharmaceutical Scientists (AAPS) has awarded its 2012 Excellence in Ligand Binding Assays Award to the Bioanalytical Development group from Morphotek for their abstract, "Development and Validation of a Pharmacokinetic Assay on the Gyrolab Platform for Use in Phase II/III Clinical Studies."

31 May 2012